Concepedia

Lingzhi Xie

LX

2

Publications

87

Citations

2

H-Index

2018

Active since

Affiliations

Research Triangle Park Foundation(Current)

Crystal Pharmatech (United States)

Lingzhi Xie is an author at Research Triangle Park Foundation specializing in drug discovery, medicine, and pharmacology.

Top concepts

MedicinePharmacologyDrug DiscoveryLung CancerCell BiologyTumor BiologyCancer TherapyCancer ResearchChemical BiologyDrug Development

Publications per year

2018–2020

2

Publications

2

Discovery of new quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors and their anticancer activities – Part 1

Debasis Das, Lingzhi Xie, Jingbing Wang et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 59 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Part 1 +13

In vivo efficacy studies of novel quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors, in lung cancer xenografts (NCI-H1975) mice models

Debasis Das, Lingzhi Xie, Jingbing Wang et al. · Bioorganic Chemistry · 2020 · 28 citations

Novel Quinazoline Derivatives, Novel Therapy, Medicine +11

Rows per page

1–2 of 2